diclofenac hydroxyethylpyrrolidine has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Althaf Hussain, S; Bi, H; Li, H; Li, J; Li, Z; Ma, Y; Peng, Z; Wang, Z; Xu, H | 1 |
| Fukamachi, K; Kim, CK; Moore, MA; Naito, A; Nomoto, H; Tsuda, H | 1 |
1 review(s) available for diclofenac hydroxyethylpyrrolidine and Prostatic Neoplasms
| Article | Year |
|---|---|
Carcinogenesis and its modification by environmental endocrine disruptors: in vivo experimental and epidemiological findings.
Topics: Animals; Breast Neoplasms; DDT; Diclofenac; Endocrine System; Environmental Pollutants; Epidemiologic Studies; Female; Glycine max; Gonadal Steroid Hormones; Humans; Insecticides; Isoflavones; Male; Mice; Neoplasms; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Prostatic Neoplasms; Rats; Risk Assessment | 2003 |
1 other study(ies) available for diclofenac hydroxyethylpyrrolidine and Prostatic Neoplasms
| Article | Year |
|---|---|
The active phthalate metabolite, DHEP, induces proliferation and metastasis of prostate cancer cells via upregulation of β-catenin and downregulation of KLF7.
Topics: Animals; beta Catenin; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Humans; Kruppel-Like Transcription Factors; Male; Mammals; Prostatic Neoplasms; Tumor Suppressor Protein p53; Up-Regulation | 2023 |